135 related articles for article (PubMed ID: 23435463)
21. miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death.
Bryant A; Palma CA; Jayaswal V; Yang YW; Lutherborrow M; Ma DD
Mol Cancer; 2012 Feb; 11():8. PubMed ID: 22348345
[TBL] [Abstract][Full Text] [Related]
22. NPM1 mutant maintains ULK1 protein stability via TRAF6-dependent ubiquitination to promote autophagic cell survival in leukemia.
Tang Y; Tao Y; Wang L; Yang L; Jing Y; Jiang X; Lei L; Yang Z; Wang X; Peng M; Xiao Q; Ren J; Zhang L
FASEB J; 2021 Feb; 35(2):e21192. PubMed ID: 33201521
[TBL] [Abstract][Full Text] [Related]
23. Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a.
Zarif MN; Soleimani M; Abolghasemi H; Amirizade N; Arefian E; Rahimian A
Hematology; 2013 Mar; 18(2):93-100. PubMed ID: 23321646
[TBL] [Abstract][Full Text] [Related]
24. Bone Marrow Clonogenic Myeloid Progenitors from
Guardia RD; González-Silva L; López-Millán B; Rodríguez-Sevilla JJ; Baroni ML; Bueno C; Anguita E; Vives S; Palomo L; Lapillonne H; Varela I; Menendez P
Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31936647
[TBL] [Abstract][Full Text] [Related]
25. Correlation of NPM1 Type A Mutation Burden With Clinical Status and Outcomes in Acute Myeloid Leukemia Patients With Mutated NPM1 Type A.
Jo SY; Park SH; Kim IS; Yi J; Kim HH; Chang CL; Lee EY; Cho YU; Jang S; Park CJ; Chi HS
Ann Lab Med; 2016 Sep; 36(5):399-404. PubMed ID: 27374703
[TBL] [Abstract][Full Text] [Related]
26. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival.
Zhang W; Zhao C; Zhao J; Zhu Y; Weng X; Chen Q; Sun H; Mi JQ; Li J; Zhu J; Chen Z; Pandolfi PP; Chen S; Yan X; Xu J
Theranostics; 2018; 8(16):4359-4371. PubMed ID: 30214626
[TBL] [Abstract][Full Text] [Related]
28. Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.
Zhou Y; Moon A; Hoyle E; Fromm JR; Chen X; Soma L; Salipante SJ; Wood BL; Wu D
Cytometry B Clin Cytom; 2019 Jan; 96(1):67-72. PubMed ID: 30417521
[TBL] [Abstract][Full Text] [Related]
29. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
30. Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications.
Sportoletti P; Varasano E; Rossi R; Mupo A; Tiacci E; Vassiliou G; Martelli MP; Falini B
Leukemia; 2015 Feb; 29(2):269-78. PubMed ID: 25179729
[TBL] [Abstract][Full Text] [Related]
31. Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.
Du Pisani LA; Shires K
Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):106-14. PubMed ID: 26183674
[TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells.
Martelli MP; Gionfriddo I; Mezzasoma F; Milano F; Pierangeli S; Mulas F; Pacini R; Tabarrini A; Pettirossi V; Rossi R; Vetro C; Brunetti L; Sportoletti P; Tiacci E; Di Raimondo F; Falini B
Blood; 2015 May; 125(22):3455-65. PubMed ID: 25795919
[TBL] [Abstract][Full Text] [Related]
33. Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia.
Wang L; Yang L; Yang Z; Tang Y; Tao Y; Zhan Q; Lei L; Jing Y; Jiang X; Jin H; Zou Q; Xian J; Zhang L
Int J Biol Sci; 2019; 15(4):882-894. PubMed ID: 30906218
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of NPM1 mutation-modulated microRNA-mRNA regulation in acute myeloid leukemia.
Chiu YC; Tsai MH; Chou WC; Liu YC; Kuo YY; Hou HA; Lu TP; Lai LC; Chen Y; Tien HF; Chuang EY
Leukemia; 2016 Feb; 30(2):274-84. PubMed ID: 26376228
[TBL] [Abstract][Full Text] [Related]
35. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
[TBL] [Abstract][Full Text] [Related]
36. [Effects of NPM1 gene expression on acute myeloid leukemia cell lines and its mechanism].
Qiu SW; Wan YL; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):940-944. PubMed ID: 29224316
[No Abstract] [Full Text] [Related]
37. Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia.
Dalal BI; Mansoor S; Manna M; Pi S; Sauro GD; Hogge DE
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):274-9. PubMed ID: 22481022
[TBL] [Abstract][Full Text] [Related]
38. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
39. Deguelin induced differentiation of mutated NPM1 acute myeloid leukemia in vivo and in vitro.
Zhang X; Zhao Z; Yi S; Wen L; He J; Hu J; Ruan J; Fang J; Chen Y
Anticancer Drugs; 2017 Aug; 28(7):723-738. PubMed ID: 28471807
[TBL] [Abstract][Full Text] [Related]
40. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
Yu Z; Li D; Ju XL
J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
